Exclusive: FDA grants RMAT designation to Enlivex’s Allocetra for knee OA
Go back to Exclusive: FDA grants RMAT designation to Enlivex’s Allocetra for knee OA| Enliven Marketing Technologies Corporation (NASDAQ: ENLV) | Delayed: 1.10 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.10 | 52 Week High | $0.94 | |||
| Open | $1.10 | 52 Week Low | $0.47 | |||
| Day High | $1.10 | P/E | N/A | |||
| Day Low | $1.10 | EPS | $-0.11 | |||
| Volume | 559 | |||||
